Fortis Capital Management »

Lyell Immunopharma shares owned by Fortis Capital Management

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Fortis Capital Management from 13F filings

Historical chart of Fortis Capital Management investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Fortis Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Fortis Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $27k 12k 2.23

More positions owned by Fortis Capital Management

Microsoft Corporation (MSFT)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Amazon (AMZN)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Spdr Gold Tr Gold Shs (GLD)
Netflix (NFLX)
Schwab Strategic Tr Us Tips Etf (SCHP)
Doximity Cl A (DOCS)
Pimco Etf Tr Inv Grd Crp Bd (CORP)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)

View all positions for Fortis Capital Management

Top funds holding Lyell Immunopharma

BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
T. Rowe Price Associates
Alphabet
Geode Capital Management
Opaleye Management
Sc China Holding
FMR
Millennium Management
MIC Capital Management UK
Massachusetts Financial Services
Northern Trust
Charles Schwab Investment Management

View all funds holding Lyell Immunopharma